TherapeuticsMD Inc (TXMD NASDAQ) stock market data APIs
$1.0569
0.03(2.8%)
as of September 17, 2025
Try our APIs with
free plan!
TherapeuticsMD Inc Financial Data Overview
Price chart is built with
Anychart
TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
Prev. Close
1.0569
Open
1.0859
High
1.0946
Low
1.0569
52 wk Range
0.7-1.8
Market Cap
12 269 K
Shares Outstanding
11 574 K
Revenue
2 559 K
EPS
0.05
Beta
0.508
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with TherapeuticsMD Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get TherapeuticsMD Inc data using free add-ons & libraries
Get TherapeuticsMD Inc Fundamental Data
TherapeuticsMD Inc Fundamental data includes:
- Net Revenue: 2 559 K
- EBITDA: -1 886 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-12
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
TherapeuticsMD Inc News
New
TherapeuticsMD Q2 Earnings Summary
(RTTNews) - Below are the earnings highlights for TherapeuticsMD (TXMD): Earnings: $0.55 million in Q2 vs. -$1.05 million in the same period last year. EPS: $0.05 in Q2 vs. -$0.09 in the same period ...
12 Best Prenatal Vitamins For Pregnant Women
In this article, we will be taking a look at the 12 best prenatal vitamins for pregnant women. If you are not interested in reading about the market insights, head straight to the 5 Best Prenatal Vita...
TherapeuticsMD Announces Third Quarter 2023 Financial Results
Focus remains on cost control to maximize the value of our royalty assets Company announces evaluation of strategic alternatives BOCA RATON, Fla., November 14, 2023--(BUSINESS WIRE)--TherapeuticsMD, ...
TherapeuticsMD Announces Second Quarter 2023 Financial Results
BOCA RATON, Fla., August 14, 2023--(BUSINESS WIRE)--TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported fina...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
